Clinical Research Institute, Inc - CRN - PPDS

Minneapolis, Minnesota 55402-2750

0 studies enrolling now · 6 studies all time

What they study most

COVID-19, Cytomegalovirus Infection, Respiratory Syncytial Virus, SARS-CoV-2

Studies at this site

• A Study of mRNA-1345 Vaccine Targeting Respiratory Syncytial Virus (RSV) in Adults ≥50 Years of Age — Completed
• A Study to Evaluate the Efficacy, Safety, and Immunogenicity of mRNA-1647 Cytomegalovirus (CMV) Vaccine in Healthy Participants 16 to 40 Years of Age — Stopped early
• A Study to Evaluate the Safety, Reactogenicity, and Effectiveness of mRNA-1273 Vaccine in Adolescents 12 to <18 Years Old to Prevent COVID-19 — Completed
• A Study to Evaluate the Safety and Efficacy of mRNA-1345 Vaccine Targeting Respiratory Syncytial Virus (RSV) in Adults ≥60 Years of Age — Completed
• A Study to Evaluate Safety and Effectiveness of mRNA-1273 COVID-19 Vaccine in Healthy Children Between 6 Months of Age and Less Than 12 Years of Age — Completed
• A Trial to Evaluate Safety and Efficacy of Rivaroxaban (COVID-19) — Stopped early